Funded Projects › FP7
HELIX · The Human Early-Life Exposome – novel tools for integrating early-life environmental exposures and child health across Europe
The aim of HELIX is to exploit novel tools and methods (remote sensing/GIS-based spatial methods, omics-based approaches, biomarkers of exposure, exposure devices and models, statistical tools for combined exposures, novel study designs, and burden of disease methodologies), to characterise early-life exposure to a wide range of environmental hazards, and integrate and link these with data on major child health outcomes (growth and obesity, neurodevelopment, immune system), thus developing an “Early-Life Exposome” approach.HELIX uses six existing, prospective birth cohort studies as the only realistic and feasible way to obtain the comprehensive, longitudinal, human data needed to build this early-life exposome. These cohorts have already collected large amounts of data as part of national and EU-funded projects. Results will be integrated with data from European cohorts (>300,000 subjects) and registers, to estimate health impacts at the large European scale.HELIX will make a major contribution to the integrated exposure concept by developing an exposome toolkit and database that will: 1) measure a wide range of major chemical and physical environmental hazards in food, consumer products, water, air, noise, and the built environment, in pre and postnatal periods; 2) integrate data on individual, temporal, and toxicokinetic variability, and on multiple exposures, which will greatly reduce uncertainty in exposure estimates; 3) determine molecular profiles and biological pathways associated with multiple exposures using omics tools; 4) provide exposure-response estimates and thresholds for multiple exposures and child health; and 5) estimate the burden of childhood disease in Europe due to multiple environmental exposures. This integration of the chemical, physical and molecular environment during critical early-life periods will lead to major improvements in health risk and impact assessments and thus to improved prevention strategies for vulnerable populations.
Consortium · 14 organisations
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA
ES
FOLKEHELSEINSTITUTTET
NO · €2,025,815
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
FR · €677,604
FUNDACIO CENTRE DE RECERCA EN EPIDEMIOLOGIA AMBIENTAL - CREAL
ES · €2,266,690
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
UK · €772,368
INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES - INERIS
FR · €163,710
PANEPISTIMIO KRITIS
EL · €402,622
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
ES · €451,194
VEILIGHEIDS- EN GEZONDHEIDSREGIO GELDERLAND-MIDDEN
NL · €148,440
HYLOBATES CONSULTING SRL
IT · €37,312
SENSING & CONTROL SYSTEMS SL
ES · €63,600
VYTAUTO DIDZIOJO UNIVERSITETAS
LT · €342,144
BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST
UK · €452,948
FUNDACIO CENTRE DE REGULACIO GENOMICA
ES · €819,493
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.